Skip to Main content Skip to Navigation
Journal articles

Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.

Abstract : Bacillus Calmette-Guérin (BCG) is currently the most effective intravesical therapy for nonmuscle invasive bladder cancer, reducing not only recurrence rates but also preventing progression and reducing deaths. However, response rates to BCG vary widely and are dependent on a multitude of factors.
Document type :
Journal articles
Complete list of metadatas

https://hal-pasteur.archives-ouvertes.fr/pasteur-01659421
Contributor : Marie-Christine Vougny <>
Submitted on : Friday, December 8, 2017 - 1:50:47 PM
Last modification on : Thursday, August 27, 2020 - 2:56:19 PM

Identifiers

Collections

Citation

Ashish Kamat, Roger Li, Michael A O'Donnell, Peter C Black, Morgan Rouprêt, et al.. Predicting Response to Intravesical Bacillus Calmette-Guérin Immunotherapy: Are We There Yet? A Systematic Review.. European Urology, Elsevier, 2017, ⟨10.1016/j.eururo.2017.10.003⟩. ⟨pasteur-01659421⟩

Share

Metrics

Record views

172